Arman Qamar: Drug-Coated Balloons in Coronary Bifurcation PCI
Arman Qamar, Founder and Director, ECCORE at Endeavor Health, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Circulation: Cardiovascular Interventions, adding:
“Pleased to share our new editorial in Circulation: Cardiovascular Interventions
Drug-Coated Balloons for Side-Branch Treatment in Coronary Bifurcations: Ready for Prime Time?
We discuss the emerging role of drug-coated balloons in bifurcation PCI, including the recent OCVC-BIF randomized trial, which demonstrated significantly lower side-branch restenosis with DCB treatment
An exciting and rapidly evolving area of complex PCI, with important questions still to be answered regarding patient selection, technique, and clinical outcomes.
Grateful to Sunil Rao, Binita Shah for the opportunity to contribute to this discussion.”
Title: Drug-Coated Balloons for Side-Branch Treatment in Coronary Bifurcations: Ready for Prime Time?
Authors: Arman Qamar, Binita Shah
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 4, 2026, 04:31Sonal Sonu: Gen Z doesn’t just set trends – Gen Z saves lives
-
Oct 4, 2026, 04:22Registration Opens for 2027 Highlights of ASH – American Society of Hematology
-
Oct 4, 2026, 04:06Konstantinos Stavroulakis: Vessel Preparation in Lower Limb Revascularization
-
Oct 4, 2026, 03:44Omid Seidizadeh: Peter Lenting Speaks at NordCoag 2026
-
Oct 4, 2026, 03:34Liselotte Hyveled: Exploring Opportunities to Improve Hemophilia and Sickle Cell Care in Ghana
-
Oct 4, 2026, 01:13Francesc Formiga: Updated Evidence on LAA Closure Versus Oral Anticoagulation in AF
-
Oct 4, 2026, 01:11Alicja Urbaniak: Targeting CD148 to Develop New Antithrombotic Therapies
-
Oct 4, 2026, 01:03Susan Mou: Presenting Long-Term Clinical Outcomes in SCD and TDT
-
Oct 4, 2026, 01:00Mark Johnson: Elevating Patient and Warrior Voices During Sickle Cell Awareness Month